{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T19:11:52Z","timestamp":1792177912354,"version":"4.4.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,7,18]],"date-time":"2015-07-18T00:00:00Z","timestamp":1437177600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s13063-015-0823-x","type":"journal-article","created":{"date-parts":[[2015,7,17]],"date-time":"2015-07-17T17:05:43Z","timestamp":1437152743000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Lamotrigine versus inert placebo in the treatment of borderline personality disorder: study protocol for a randomized controlled trial and economic evaluation"],"prefix":"10.1186","volume":"16","author":[{"given":"Mike J.","family":"Crawford","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahil","family":"Sanatinia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Byford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kavi","family":"Gakhal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geof","family":"Lawrence-Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verity","family":"Leeson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenella","family":"Lemonsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia","family":"Lykomitrou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Montgomery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Morriss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Paton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Tyrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph G.","family":"Reilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,7,18]]},"reference":[{"key":"823_CR1","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"1994","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington DC: American Psychiatric Association; 1994.","edition":"4"},{"key":"823_CR2","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1192\/bjp.188.5.423","volume":"188","author":"J Coid","year":"2006","unstructured":"Coid J, Yang M, Tyrer P, Roberts A, Ullrich S. Prevalence and correlates of personality disorder in Great Britain. Br J Psychiatry. 2006;188:423\u201331.","journal-title":"Br J Psychiatry"},{"key":"823_CR3","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1176\/ps.2006.57.4.538","volume":"57","author":"M Hayward","year":"2006","unstructured":"Hayward M, Slade M, Moran PA. Personality disorders and unmet needs among psychiatric inpatients. Psychiatr Serv. 2006;57:538\u201343.","journal-title":"Psychiatr Serv"},{"key":"823_CR4","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1176\/appi.ajp.159.2.276","volume":"159","author":"AE Skodol","year":"2002","unstructured":"Skodol AE, Gunderson JG, McGlashan TH, Dyck IR, Stout RL, Bender DS, et al. Functional impairment in patients with schizotypal, borderline, avoidant, or obsessive-compulsive personality disorder. Am J Psychiatry. 2002;159:276\u201383.","journal-title":"Am J Psychiatry"},{"key":"823_CR5","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/S0140-6736(04)16770-6","volume":"364","author":"K Lieb","year":"2004","unstructured":"Lieb K, Zanarini MC, Schmahl C, Linehan MM, Bohus M. Borderline personality disorder. Lancet. 2004;364:453\u201361.","journal-title":"Lancet"},{"key":"823_CR6","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1111\/j.1600-0447.2011.01728.x","volume":"124","author":"MJ Crawford","year":"2011","unstructured":"Crawford MJ, Kakad S, Rendell C, Mansour NA, Crugel M, Liu KW, et al. Medication prescribed to people with personality disorder: the influence of patient factors and treatment setting. Acta Psychiatr Scand. 2011;124:396\u2013402.","journal-title":"Acta Psychiatr Scand"},{"key":"823_CR7","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.seizure.2004.02.005","volume":"14","author":"S Sukumaran","year":"2005","unstructured":"Sukumaran S, Herbert J, Tracey J, Delanty N. Safety of newer generation anti-epileptic drugs in non-accidental overdose: an Irish population study. Seizure. 2005;14:151\u20136.","journal-title":"Seizure"},{"key":"823_CR8","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0074-7742(08)00011-1","volume":"83","author":"CL Harden","year":"2008","unstructured":"Harden CL. Antiepileptic drug teratogenesis: what are the risks for congenital malformations and adverse cognitive outcomes? Int Rev Neurobiol. 2008;83:205\u201313.","journal-title":"Int Rev Neurobiol"},{"key":"823_CR9","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1177\/0269881105051540","volume":"19","author":"K Tritt","year":"2005","unstructured":"Tritt K, Nickel C, Lahmann C, Leiberich PK, Rother WK, Loew TH, et al. Lamotrigine treatment of aggression in female borderline-patients: a randomized, double-blind, placebo-controlled study. J Psychopharmacol. 2005;19:287\u201391.","journal-title":"J Psychopharmacol"},{"key":"823_CR10","first-page":"270","volume":"24","author":"DB Reich","year":"2009","unstructured":"Reich DB, Zanarini MC, Bieri KA. A preliminary study of lamotrigine in the treatment of affective instability in borderline personality disorder. Int Clin Psychopharmacol. 2009;24:270\u20135.","journal-title":"Int Clin Psychopharmacol"},{"key":"823_CR11","volume-title":"Structured Clinical Interview for DSM-IV Axis II Personality Disorders (SCID-II), version 2.0","author":"MB First","year":"1997","unstructured":"First MB, Spitzer RL, Gibbon M, Williams JB, Benjamin L. Structured Clinical Interview for DSM-IV Axis II Personality Disorders (SCID-II), version 2.0. Washington, DC: American Psychiatric Press, Inc.; 1997."},{"key":"823_CR12","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1521\/pedi.1997.11.3.279","volume":"11","author":"C Maffei","year":"1997","unstructured":"Maffei C, Fossati A, Agostoni I, Barraco A, Bagnato M, Deborah D, et al. Interrater reliability and internal consistency of the structured clinical interview for DSM-IV axis II personality disorders (SCID-II), version 2.0. J Pers Disord. 1997;11:279\u201384.","journal-title":"J Pers Disord"},{"key":"823_CR13","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1176\/ajp.153.12.1593","volume":"153","author":"P Tyrer","year":"1996","unstructured":"Tyrer P, Johnson T. Establishing the severity of personality disorder. Am J Psychiatry. 1996;153:1593\u20137.","journal-title":"Am J Psychiatry"},{"key":"823_CR14","volume-title":"Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version","author":"MB First","year":"2002","unstructured":"First MB, Spitzer RL, Gibbon M, Williams JB. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version. New York: Biometrics Research: New York State Psychiatric Institute; 2002."},{"key":"823_CR15","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1111\/bdi.12101","volume":"15","author":"A Gamma","year":"2013","unstructured":"Gamma A, Angst J, Azorin JM, Bowden CL, Perugi G, Vieta E, et al. Transcultural validity of the Hypomania Checklist-32 (HCL-32) in patients with major depressive episodes. Bipolar Disord. 2013;15:701\u201312.","journal-title":"Bipolar Disord"},{"key":"823_CR16","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1521\/pedi.17.3.233.22147","volume":"17","author":"MC Zanarini","year":"2003","unstructured":"Zanarini MC, Parachini EA, Boulanger JL, Frankenburg FR, Hennen J. Zanarini Rating Scale for Borderline Personality Disorder (ZAN-BPD): a continuous measure of DSM-IV borderline psychopathology. J Pers Disord. 2003;17:233\u201342.","journal-title":"J Pers Disord"},{"key":"823_CR17","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1053\/comp.2002.33497","volume":"43","author":"N Blum","year":"2002","unstructured":"Blum N, Pfohl B, John DS, Monahan P, Black DW. STEPPS: a cognitive-behavioral systems-based group treatment for outpatients with borderline personality disorder--a preliminary report. Compr Psychiatry. 2002;43:301\u201310.","journal-title":"Compr Psychiatry"},{"key":"823_CR18","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.4088\/JCP.08m04138yel","volume":"72","author":"MC Zanarini","year":"2011","unstructured":"Zanarini MC, Schulz SC, Detke HC, Tanaka Y, Zhao F, Lin D, et al. A dose comparison of olanzapine for the treatment of borderline personality disorder: a 12-week randomized, double-blind, placebo-controlled study. J Clin Psychiatry. 2011;72:1353\u201362.","journal-title":"J Clin Psychiatry"},{"key":"823_CR19","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","volume":"4","author":"A Beck","year":"1961","unstructured":"Beck A, Ward C, Mendekson M, Mock JJE. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561\u201371.","journal-title":"Arch Gen Psychiatry"},{"key":"823_CR20","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/0272-7358(88)90050-5","volume":"8","author":"AT Beck","year":"1988","unstructured":"Beck AT, Steer RA, Garbin MG. Psychometric properties of the Beck Depression Inventory: twenty-five years later. Clin Psychol Rev. 1988;8:77\u2013100.","journal-title":"Clin Psychol Rev"},{"key":"823_CR21","doi-asserted-by":"crossref","DOI":"10.4324\/9780203945902","volume-title":"Cognitive Therapy for Personality Disorders: A Guide for Clinicians","author":"KM Davidson","year":"2007","unstructured":"Davidson KM. Cognitive Therapy for Personality Disorders: A Guide for Clinicians. 2nd ed. Hove, UK: Routledge; 2007.","edition":"2"},{"key":"823_CR22","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1521\/pedi.2006.20.5.466","volume":"20","author":"S Palmer","year":"2006","unstructured":"Palmer S, Davidson K, Tyrer P, Gumley A, Tata P, Norrie J, et al. The cost-effectiveness of cognitive behavior therapy for borderline personality disorder: results from the BOSCOT trial. J Pers Disord. 2006;20:466\u201381.","journal-title":"J Pers Disord"},{"key":"823_CR23","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1177\/0020764005057391","volume":"51","author":"P Tyrer","year":"2005","unstructured":"Tyrer P, Nur U, Crawford M, Karlsen S, McLean C, Rao B, et al. The Social Functioning Questionnaire: a rapid and robust measure of perceived functioning. Int J Soc Psychiatry. 2005;51:265\u201375.","journal-title":"Int J Soc Psychiatry"},{"key":"823_CR24","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0168-8510(96)00822-6","volume":"37","author":"R Brooks","year":"1996","unstructured":"Brooks R. EuroQol: the current state of play. Health Policy. 1996;37:53\u201372.","journal-title":"Health Policy"},{"key":"823_CR25","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.eurpsy.2008.11.001","volume":"24","author":"AD Asselt van","year":"2009","unstructured":"van Asselt AD, Dirksen CD, Arntz A, Giesen-Bloo JH, Severens JL. The EQ-5D: a useful quality of life measure in borderline personality disorder? Eur Psychiatry. 2009;24:79\u201385.","journal-title":"Eur Psychiatry"},{"key":"823_CR26","volume-title":"British National Formulary 68","author":"British National Formulary","year":"2013","unstructured":"British National Formulary. British National Formulary 68. London: British Medical Association and Royal Pharmaceutical Society of Great Britain; 2013."},{"key":"823_CR27","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1046\/j.1360-0443.2002.00185.x","volume":"97","author":"WHO ASSIST Working Group","year":"2002","unstructured":"WHO ASSIST Working Group. The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): development, reliability and feasibility. Addiction. 2002;97:1183\u201394.","journal-title":"Addiction"},{"key":"823_CR28","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1080\/09595230500170266","volume":"24","author":"DA Newcombe","year":"2005","unstructured":"Newcombe DA, Humeniuk RE, Ali R. Validation of the World Health Organization Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): report of results from the Australian site. Drug Alcohol Rev. 2005;24:217\u201326.","journal-title":"Drug Alcohol Rev"},{"key":"823_CR29","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1192\/bjp.bp.112.117762","volume":"202","author":"R Borschmann","year":"2013","unstructured":"Borschmann R, Barrett B, Hellier JM, Byford S, Henderson C, Rose D, et al. Joint crisis plans for people with borderline personality disorder: feasibility and outcomes in a randomized controlled trial. Br J Psychiatry. 2013;202:357\u201364.","journal-title":"Br J Psychiatry"},{"key":"823_CR30","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1046\/j.1365-2125.2000.00244.x","volume":"50","author":"CF George","year":"2000","unstructured":"George CF, Peveler RC, Heiliger S, Thompson C. Compliance with tricyclic antidepressants: the value of four different methods of assessment. Br J Clin Pharmacol. 2000;50:166\u201371.","journal-title":"Br J Clin Pharmacol"},{"key":"823_CR31","volume-title":"Guide to the Methods of Technology Appraisal","author":"National Institute for Health and Care Excellence","year":"2008","unstructured":"National Institute for Health and Care Excellence. Guide to the Methods of Technology Appraisal. London: National Institute for Health and Care Excellence; 2008."},{"key":"823_CR32","volume-title":"Unit Costs of Health and Social Care 2013","author":"L Curtis","year":"2014","unstructured":"Curtis L. Unit Costs of Health and Social Care 2013. Canterbury, UK: Personal Social Services Research Unit; 2014."},{"key":"823_CR33","volume-title":"National Schedule of Reference Costs 2013\u201314 for NHS Trusts and NHS Foundation Trusts","author":"Department of Health","year":"2014","unstructured":"Department of Health. National Schedule of Reference Costs 2013\u201314 for NHS Trusts and NHS Foundation Trusts. London: Department of Health; 2014."},{"key":"823_CR34","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4899-4541-9","volume-title":"An Introduction to the Bootstrap","author":"B Efron","year":"1993","unstructured":"Efron B, Tibshirani RJ. An Introduction to the Bootstrap. New York: Chapman Hall; 1993."},{"key":"823_CR35","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1002\/1097-0258(20001215)19:23<3219::AID-SIM623>3.0.CO;2-P","volume":"19","author":"JA Barber","year":"2000","unstructured":"Barber JA, Thompson SG. Analysis of cost data in randomized trials: an application of the non-parametric bootstrap. Stat Med. 2000;19:3219\u201336.","journal-title":"Stat Med"},{"key":"823_CR36","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/hec.4730030505","volume":"3","author":"BA Hout Van","year":"1994","unstructured":"Van Hout BA, Al MJ, Gordon GS, Rutten FH. Costs, effects and cost-effectiveness ratios alongside a clinical trial. Health Econ. 1994;3:309\u201319.","journal-title":"Health Econ"},{"key":"823_CR37","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1192\/bjp.187.2.106","volume":"187","author":"E Fenwick","year":"2005","unstructured":"Fenwick E, Byford S. A guide to cost-effectiveness acceptability curves. Br J Psychiatry. 2005;187:106\u20138.","journal-title":"Br J Psychiatry"},{"key":"823_CR38","volume-title":"Borderline Personality Disorder \u2013 The NICE Guideline on Treatment and Management","author":"National Institute for Health and Care Excellence","year":"2009","unstructured":"National Institute for Health and Care Excellence. Borderline Personality Disorder \u2013 The NICE Guideline on Treatment and Management. London: National Institute for Health and Care Excellence; 2009."},{"key":"823_CR39","volume-title":"Clinical Practice Guideline for the Management of Borderline Personality Disorder","author":"National Health and Medical Research Council","year":"2012","unstructured":"National Health and Medical Research Council. Clinical Practice Guideline for the Management of Borderline Personality Disorder. Melbourne: National Health and Medical Research Council; 2012."},{"key":"823_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1176\/appi.ajp.158.1.1","volume":"158","author":"American Psychiatric Association Practice Guidelines","year":"2001","unstructured":"American Psychiatric Association Practice Guidelines. Practice guideline for the treatment of patients with borderline personality disorder. Am J Psychiatry. 2001;158:1\u201352.","journal-title":"Am J Psychiatry"},{"key":"823_CR41","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1192\/bjp.bp.108.062984","volume":"196","author":"K Lieb","year":"2010","unstructured":"Lieb K, Vollm B, Rucker G, Timmer A, Stoffers JM. Pharmacotherapy for borderline personality disorder: Cochrane systematic review of randomized trials. Br J Psychiatry. 2010;196:4\u201312.","journal-title":"Br J Psychiatry"},{"key":"823_CR42","doi-asserted-by":"publisher","first-page":"g5378","DOI":"10.1136\/bmj.g5378","volume":"349","author":"MJ Crawford","year":"2014","unstructured":"Crawford MJ, MacLaren T, Reilly JG. Are mood stabilisers helpful in treatment of borderline personality disorder? BMJ. 2014;349:g5378. doi:\n                    10.1136\/bmj.g5378\n                    \n                  .","journal-title":"BMJ"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-015-0823-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13063-015-0823-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-015-0823-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-015-0823-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T22:51:54Z","timestamp":1553640714000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-015-0823-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,18]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["823"],"URL":"https:\/\/doi.org\/10.1186\/s13063-015-0823-x","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,18]]},"assertion":[{"value":"2 March 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"308"}}